Your browser doesn't support javascript.
loading
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.
Segar, Matthew W; Kolkailah, Ahmed A; Frederich, Robert; Pong, Annpey; Cannon, Christopher P; Cosentino, Francesco; Dagogo-Jack, Samuel; McGuire, Darren K; Pratley, Richard E; Liu, Chih-Chin; Maldonado, Mario; Liu, Jie; Cater, Nilo B; Pandey, Ambarish; Cherney, David Z I.
Afiliación
  • Segar MW; Department of Cardiology, Texas Heart Institute, Houston, Texas, USA.
  • Kolkailah AA; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Frederich R; Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Pong A; Biostatistics and Research Decision Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Cosentino F; Unit of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm, Sweden.
  • Dagogo-Jack S; Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • McGuire DK; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Pratley RE; Parkland Health and Hospital System, Dallas, Texas, USA.
  • Liu CC; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Maldonado M; Biostatistics and Research Decision Sciences, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Liu J; MSD Limited, London, UK.
  • Cater NB; Global Clinical Development - Diabetes, Endocrinology & Metabolism, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Pandey A; Pfizer Inc., New York, New York, USA.
  • Cherney DZI; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Diabetes Obes Metab ; 24(9): 1829-1839, 2022 09.
Article en En | MEDLINE | ID: mdl-35603908

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Cardíaca Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos